Andreas Mantoulidis,Peter Ettmayer,Steffen Steurer
申请号：
BRPI0920608
公开号：
BRPI0920608A2
申请日:
2009.09.28
申请国别(地区):
BR
年份:
2019
代理人:
摘要：
The present invention relates to new compounds of general formula (I), wherein the groups R1 to R3, X1, X2, X3 and L1 are defined as in claim 1, which are suitable for the treatment of diseases characterised by excessive or abnormal cell proliferation, and the use thereof in such a treatment.
